Danina Fisher
Danina Fisher has made 1 open-market purchase worth $10k since Oct 2, 2026, in 1 company. The latest: $10k of HEPA, filed Oct 2, 2026, scored 19 out of 100.
Director, Hepion Pharmaceuticals, Inc.
Follow Danina Fisher, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 2 Form 4 (opens sec.gov) |
HEPAHepion Pharmaceuticals, Inc. · DirectorDirector · Filed late · Penny stock: hard to trade | New position | 19 | $10k 200,000 at $0.05 |
— | — |
Questions
What stock has Danina Fisher bought?
HEPA (Hepion Pharmaceuticals, Inc.), all on the open market and reported on SEC Form 4.
When did Danina Fisher last buy?
Oct 2, 2026: 200,000 shares of HEPA at $0.05, $10k in all (Form 4 (opens sec.gov)).
Has Danina Fisher filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Danina Fisher a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 2, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer